-- BV Market Projected to Reach $1.0 Billion in the U.S. by 2033 -- -- BV Affects 21 Million U.S. Women; As many as 50% Experience Recurrent BV Within Six Months of Treatment -- SAN DIEGO, June 11, 2025 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM) today...
Read More Details
Finally We wish PressBee provided you with enough information of ( Notable Data on Evofem's SOLOSEC in Recurrent Bacterial Vaginosis (BV) Released at ACOG Annual Meeting )
Also on site :
- Northern Ireland riots latest: Petrol bombs and fireworks hurled at police as Ballymena violence spreads
- Numbrix 9 - June 12
- US sanctions ICC judges: RT examines why (VIDEO)